You can expect an opinion from some of the most qualified physicians in the world.
Read about some of our featured specialists and the kind of experience that’s behind every consultation we provide.
Co-Clinical Director, Center for Sarcoma and Bone Oncology
Medical Oncology, 2007
Internal Medicine, 2004
Johns Hopkins School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Medical Oncology, 2007
Brown University School of Medicine, Internal Medicine, 2004
Mount Sinai School of Medicine, 2001
Dr. Daniel Deschler has spent more than two decades dedicated to improving cancer care and reconstruction. He received his honors degree in medicine from Harvard Medical School prior to completing his residency in otolaryngology—head and neck surgery from the University of California, San Francisco. He then completed an advanced fellowship in head and neck surgical oncology and microvascular reconstruction with Dr. Richard Hayden at Hahnemann University Hospital. Dr. Deschler returned to Boston in 2000 to join the staff at Mass. Eye and Ear and now serves as the Vice Chair of Academic Affairs in the Department of Otolaryngology at Mass. Eye and Ear, the Director of the Norman Knight Center for Hyperbaric Medicine, the Co-Director of the Michael Dingman Fellowship in Head and Neck/Microvascular Surgery, a member of the Center for Thyroid Eye Disease and Orbital Surgery, and a Professor of Otolaryngology at Harvard Medical School.
Dr. Deschler has authored more than 150 peer-reviewed publications, as well as numerous book chapters and education reviews. He serves on the editorial board of several publications, is an Associate Editor for Otolaryngology—Head and Neck Surgery, and is a reviewer for 18 journals. He has served as Chairman of the Head and Neck Surgery Committee of the American Academy of Otolaryngology—Head and Neck Surgery for the last six years and is the Past President of the Society of University Otolaryngologist—Head and Neck Surgeons, after having served as Secretary/Treasurer.
Dr. Deschler’s clinical interests cover the breadth of head and neck oncologic and reconstructive surgery including, advanced malignancies of the upper aerodigestive tract, salivary gland diseases, microvascular reconstruction, and general head and neck reconstruction.
His research interests include investigations into the prevention of thrombosis in microvascular surgery, speech following pharyngeal reconstruction, and management issues in the treatment of advanced head and neck malignancies.
Clinical Director of Hepatology at Brigham & Women's Hospital
Harvard Medical School, 2000
Brigham and Women's Hospital, Internal Medicine, 2003
Massachusetts General Hospital, Gastroenterology, 2006
Massachusetts General Hospital, Hepatology, 2007
Transplant Hepatology, 2008
end-stage liver disease
women's GI health
Chief, Orthopaedic Oncology Service
Dalhousie University, 1982
Dalhousie University, Orthopedic Surgery, 1987
Massachusetts General Hospital, Orthopedic Surgery, 1989
St. Michael's Hospital, Toronto, Canada, Orthopedic Surgery, 1989
Orthopedic Surgery, 1991
knee problems and injuries
musculoskeletal conditions and injuries
Clinical Director, Melanoma Center
Clinical Director, Center for Immuno-Oncology Physician
Medical Oncology, 2008
Internal Medicine, 2005
New York University School of Medicine, Hematology and Oncology, 2008
Case Western Reserve University, Internal Medicine, 2005
Ludwig Maximilians, University of Munich
Kerry J. Ressler, MD, PhD, is Chief Scientific Officer and James and Patricia Poitras Chair in Psychiatry at McLean Hospital, after serving at Emory University for 18 years. He is also a professor in psychiatry at Harvard Medical School and current president of the Society for Biological Psychiatry. Dr. Ressler was previously an investigator of the Howard Hughes Medical Institute and is a member of the National Academy of Medicine (formerly the Institute of Medicine) and the National Academy of Medicine
Dr. Ressler’s lab focuses on translational research bridging molecular neurobiology in animal models with human genetic research on emotion, particularly fear and anxiety disorders. He has published over 225 manuscripts ranging from basic molecular mechanisms of fear processing to understanding how emotion is encoded in a region of the brain called the amygdala, in both animal models and human patients.
Beth L. Murphy, MD, PhD, is the medical director of McLean Hospital's Clinical Evaluation Center (CEC), a unit that specializes in evaluating individuals in acute psychiatric crisis who may need inpatient hospitalization. The CEC sees individuals with a broad range of psychiatric disorders, which matches her interest in diagnostic assessment and acute stabilization. She works with the unit’s administrative staff to develop policies and procedures that will ensure efficient, safe, and compassionate care for all patients and has several ongoing initiatives related to efficiency, disposition, and patient experience.
Dr. Murphy participates in the training of psychiatry residents, psychology interns, advanced practice nursing students, and medical students. She also has ongoing research interests, currently focused around the assessment of safety and suicidality.
Brent P. Forester, MD, MSc, is an expert in geriatric psychiatry specializing in the treatment of older adults with depression, bipolar disorder, and behavioral complications of Alzheimer’s disease and related dementias. He is Chief of the Division of Geriatric Psychiatry at McLean Hospital and medical director for Behavioral Health in Population Health Management at Partners HealthCare. A member of the Board of Directors and current secretary/treasurer of the American Association for Geriatric Psychiatry, he recently completed service as a board director and chair of the Medical Scientific Committee of the Alzheimer’s Association of Massachusetts/New Hampshire.
Dr. Forester’s research focuses on using brain imaging techniques and careful clinical assessment to better understand the causes of depression and bipolar disorder in later life and to identify promising new targets for effective treatments. He also studies novel treatment approaches to manage the common behavioral complications of dementia, such as agitation and aggression.
Ipsit Vahia, MD, is a geriatric psychiatrist, clinician and researcher. He is the medical director of the Geriatric Psychiatry Outpatient Services at McLean Hospital. His research focuses on the use of technology and informatics in the assessment and management of older adults. He has published over 40 papers and 20 chapters in major international textbooks. He is currently engaged in implementing a program on aging, behavior, and technology at McLean.
Dr. Vahia serves on the Board of Directors of the American Association for Geriatric Psychiatry (AAGP) and the American Psychiatric Association (APA) Council on Geriatric Psychiatry and has served on the editorial boards of the American Journal of Geriatric Psychiatry and the Journal of Clinical Psychiatry. A John A. Hartford Foundation Scholar from 2011-2016, he is a recipient of several prestigious awards including the 2016 AAGP Barry Lebowitz Award and the 2014 APA Hartford Jeste Award.
J. Alexander Bodkin, MD, has been at McLean since 1985. Working with Dr. Jonathan Cole until his death, Dr. Bodkin has long pursued the study of new and old medications for depression and anxiety. His research has focused on underutilized pharmacologic approaches to difficult-to-treat mood and anxiety disorders, such as MAO inhibitors, stimulants, and the opioid buprenorphine. Dr. Bodkin directs clinical trials of potential antidepressants, anxiolytics, and adjunctive medications intended to relieve treatment-resistant depression and the residual symptoms of partially treatment-responsive depression.
Dr. Bodkin’s consulting practice focuses on the diagnosis and optimal treatment of psychiatric illness. He is also interested in the widespread misuse of the PTSD diagnosis in civil litigation and in legal issues concerning the causation of psychiatric illness. He has been involved in the repressed memory controversy, and has studied ethical issues arising in mental health care.
The overarching theme of Dr. Brennan's research is the investigation of novel biological targets for the development of improved pharmacologic therapies for mood and anxiety disorders. Specifically, Dr. Brennan focuses on the use of neuroimaging as a means to better understand the mechanism of action of both standard and novel treatments for mood and anxiety disorders, and to identify neurochemical and functional mediators of treatment response.
Dr. Brennan's clinical and research work has led to grant funding from the National Institute of Mental Health, NARSAD, the Sidney R. Baer, Jr. Foundation, and the Stanley Medical Research Institute, and also to receipt of the Outstanding Professional of the Year Award from the Boston chapter of the Depression and Bipolar Disorder Support Alliance.
Dr. Shinn is co-medical director of McLean OnTrackTM, a program for first episode psychosis, director of clinical research in the Schizophrenia and Bipolar Disorder Research Program, and an assistant professor of psychiatry at Harvard Medical School.
Dr. Shinn's current research focus is in understanding the neurobiology of symptom dimensions in psychosis. She is the principal investigator of a federally funded research grant (K23 award) to investigate how auditory, speech, and language regions are connected in the brains of individuals who hear voices.
A native of Istanbul, Turkey, Dr. Öngür has a background in neuroscience and clinical psychiatry. He is currently the chief of the Psychotic Disorders Division, responsible for two inpatient units, a residential facility, and a specialty outpatient clinic. In addition to his clinical work, he receives funding from the National Institute of Mental Health and others for his research using brain imaging techniques to study chemical abnormalities in patients with schizophrenia and bipolar disorder.
Dr. Öngür is currently an associate professor of psychiatry at Harvard Medical School and the author of more than 80 articles on research into the neurobiology of bipolar disorder and schizophrenia. He has won awards from Harvard Medical School for his teaching of medical students and residents and for mentoring, and also serves as the associate editor of JAMA Psychiatry, a premier journal in the field.
Fernando Rodriguez-Villa, MD is the medical director of the Short Term Unit, North in the Division of Depression and Anxiety Disorders. His main areas of interest include mood disorders, suicide, college mental health, medical education, stigma reduction and cross-cultural psychiatry. He serves on the Patient Family Advisory Committee and is co-chair of the Stigma Committee at McLean.
Dr. Rodriguez-Villa was the director of hospital services at the Massachusetts Mental Health Center; and the director of the psychiatric crisis service at Beth Israel Hospital. Born in Havana, Cuba, he earned his BS at the University of Puerto Rico and his MD from the College of Physicians and Surgeons, Columbia University. He completed his psychiatric residency at New York Hospital-Cornell Medical Center and Beth Israel Hospital.
Nelya Melnitchouk is Director of Peritoneal Malignancy Program, an associate surgeon at Brigham and Women’s Hospital (BWH)and instructor of surgery at Harvard Medical School.
Dr. Melnitchouk received her medical degree from Albert Einstein College of Medicine. She completed her general surgery residency at Brigham and Women’s Hospital/Harvard Medical School. She completed a colorectal surgery fellowship at the combined Memorial Sloan Kettering Cancer Center and New York Hospital/Weill Cornell Medical Center Colorectal Surgery Program. She is board certified in general surgery and Colon and Rectal Surgery.
Her clinical interests include appendiceal and colorectal cancer with peritoneal spread, heated intraperitoneal chemotherapy (HIPEC), minimally invasive surgery (laparoscopic, robotic and combined endoscopic laparoscopic surgery), sphincter preserving/saving surgery in rectal cancer, colon and rectal cancer, inflammatory bowel disorders. Her research interests are in outcomes research and global health; colorectal cancer screening and surgery for colorectal cancer in low-to-middle income countries; gastrointestinal complications involving cardiac surgery patients with LVAD and heart transplant; and sphincter sparing surgery for rectal cancer.
Brittany Bychkovsky is an attending physician at Dana-Farber Cancer Institute and an Instructor of Medical Oncology at Harvard Medical School. In her clinical practice, she cares for patients with both early and advanced breast cancer. She also is a Cancer Genetics and Prevention specialist and performs cancer risk assessments for patients and their families. As a researcher, she has a strong interest in studying how oncologists practice and developing systems to improve the quality of care that we provide to cancer patients. She recently reviewed the use of baseline imaging for women with asymptomatic Stage II breast cancer and found that many patients underwent CT imaging to screen for distant occult metastases despite guideline recommendations indicating that there is no role for imaging in this setting. As part of another project, she is studying treatment patterns and clinical outcomes for women with metastatic breast cancer in the era of personalized medicine and targeted therapy. She is an advocate for improving cancer care both domestically and internationally, and has been involved in reviewing the status of cancer care in low- and middle-income countries for Lancet Oncology.
Our work focuses most generally on the types of brain tumors called gliomas that affect adults and children. Several of our projects have identified the transcription factor networks that control normal and tumorigenic neural stem/progenitor cells and applied these findings to improve diagnosis and treatment of brain tumor patients. Our group uses a variety of approaches including primary human tissue and cancer "stem" cell models, mouse genetics, integrative genomics, translational human research, and molecular neuropathology.
A key area of expertise in my lab is the development of sophisticated human patient derived cell lines (PDCLs) and patient derived xenografts (PDX) which serve as "patient avatars" or model systems. These models allow us to more accurately study brain tumors outside of patients and develop new treatments in collaboration with pharmaceutical partners and academic institutions.
My lab is involved in several national clinical trials of brain tumors and translational research studies to identify improved genetic and pathologic markers of human brain tumors. Using integrative genomics, preclinical modeling and clinical outcomes data analysis these studies have lead to planning and performance of more ‘personalized’ clinical trials through collaboration with the broader neurooncology community at the DFCI, BWH and CHB.
As a member of the Center for Molecular Oncologic Pathology at the DFCI/BWH, our lab also seeks to develop improved techniques for evaluation of human cancer pathways that can be directly translated into clinical diagnostic practice at the BWH clinical labs.
Our lab also aids the broader neurooncology community by directing the Neuroonocology Program Tissue Bank and the Living Tissue Bank activities for the members of the DF/BWCC.
Dr. Paul M. Busse is the Clinical Director of the Department of Radiation Oncology at Massachusetts General Hospital and Chief of the Head and Neck Oncology Division. He is an Associate Professor at Harvard Medical School. Dr. Busse obtained a Ph.D. in Microbiology (Cellular and Radiation Biology) from St. Louis University and an MD cum laude from St. Louis University with election to AOA. He was a medical intern in Internal Medicine, Barnes Hospital, Washington University then resident and Chief Resident in Radiation Medicine at Massachusetts General Hospital. He practiced from 1986 to 2003 at the Harvard Joint Center for Radiation Therapy and from 2003 until present at MGH
Dr. LaCasce is Director, Dana-Farber/Partners CancerCare Hematology-Medical Oncology Fellowship Program and
Dr. LaCasce received her MD at Tufts University School of Medicine in 1996. She completed postgraduate training in Internal Medicine at Brigham & Women's Hospital, followed by a fellowship in Hematology and Oncology at Dana-Farber Cancer Institute. She is currently a member of the DFCI Hematologic Malignancies staff.
Dr. Antin is Chief and Program Director, Stem Cell Transplantation
Institute at Dana Farber Cancer Institute. He is Professor of Medicine, Harvard Medical School.
Dr. Antin received his MD from Cornell University in 1978, and postgraduate training in hematology and medical oncology at DFCI and Brigham and Women's Hospital. He subsequently served as director of the Bone Marrow Transplantation Service at BWH from 1987 to 1997. He now heads the Stem Cell Transplant Program of the Department of Medical Oncology at DFCI and BWH. He is a founding member and past president of the American Society of Blood and Marrow Transplantation and a past Chairman of the Steering Committee of the BMT Clinical Trial Network.
Dr. Hahn is Chair, Executive Committee for Research; Deputy Chief Scientific Officer; Chief, Division of Molecular and Cellular Oncology; Director, Center for Cancer Genome Discovery at Dana Farber Cancer Institute. He is Professor of Medicine, Harvard Medical School
Dr. Hahn received his MD and PhD from Harvard Medical School in 1994. He then completed clinical training in internal medicine at Massachusetts General Hospital and medical oncology at DFCI. He conducted his postdoctoral studies with Dr. Robert Weinberg at the Whitehead Institute and joined the faculty of DFCI and Harvard Medical School in 2001.
Dr Pasi A. Jänne is Director, Lowe Center for Thoracic Oncology; Scientific Director, Belfer Institute for Applied Cancer Science and Senior Physician at Dana Farber Cancer Institute. He Professor of Medicine at Harvard Medical School.
Dr. Jänne received his M.D. and Ph.D. degrees from University of Pennsylvania in 1996. He completed post-graduate training at the Brigham and Women’s Hospital in internal medicine and at the Dana Farber Cancer Institute in Medical Oncology in 2001. His main research interests include the study of epidermal growth factor receptor mutations in non-small cell lung cancer and their impact on the efficacy of EGFR targeted therapeutic agents.
Alison Friedmann, MD: Staff Pediatrician at Massachusetts General Hospital; Assistant Professor, Harvard Medical School.
Practicing Pediatric Oncology for over 7-years, Dr. Friedmann has special interests in Acute Lymphoblastic Leukemia (ALL), Hodgkin’s disease, and rhabdomyosarcoma. Educated at Dartmouth Medical School, Dr. Friedmann completed her Pediatrics Residency at Dartmouth-Hitchcock Medical Center and Pediatric Hematology/Oncology Fellowship at Johns Hopkins Hospital. Board Certified in Pediatrics and Pediatric Hematology-Oncology, Dr. Friedmann maintains clinical interests in the supportive care of pediatric oncology patients, and is actively involved in clinical research both locally and nationally in the Children’s Oncology Group. Dr. Friedmann is the recipient of many awards and honors and has written extensively for various peer-reviewed medical journals.
Dr. Meyerhardt is Clinical Director, Gastrointestinal Cancer Center
Senior Physician at Dana Farber Cancer Institute. He is Associate Professor of Medicine, Harvard Medical School.
Dr. Meyerhardt received his MD from Yale School of Medicine in 1997. He completed a residency in internal medicine at Beth Israel Deaconness Medical Center, in Boston, followed by a medical oncology fellowship at DFCI. He joined the Gastrointestinal Cancer Center at DFCI in 2002. He is actively involved in the care of patients with various gastrointestinal cancers, including esophagus, gastric, pancreatic, colorectal, and liver cancers.
Dr. Burstein is a Senior Physician at Dana Farber Cancer Institute. He is Associate Professor of Medicine, Harvard Medical School.
Dr. Burstein graduated from Harvard College before earning his MD at Harvard Medical School. He also received a PhD in cellular immunology and a master's degree in the history of science from Harvard. He trained in internal medicine at Massachusetts General Hospital before his oncology fellowship at DFCI. In 1999, he joined the staff of DFCI and Brigham and Women's Hospital, where he is a clinician and clinical investigator in the Breast Oncology Center. Dr. Burstein is actively involved in clinical trials for both early- and late-stage breast cancer. He has served on several ASCO panels to define standards of care for breast cancer therapy, and is on the NCCN Breast Cancer Panel and the CALGB Breast Cancer committee. Dr. Burstein's publications can be found in the New England Journal of Medicine, the Journal of Clinical Oncology, and other leading medical journals.
Adolph Matthew Hutter, Jr, MD, is Professor of Medicine at Harvard Medical School in Boston and Clinical Cardiologist at Massachusetts General Hospital, also in Boston. He is Director of the Cardiac Performance Program at the Heart Center of the MGH.
He has authored or coauthored of over 150 journal articles, reviews, book chapters and invited papers. He is a general adult clinical cardiologist with special interests in coronary artery disease, valvular heart disease, and the athletic heart. He teaches at lectures, both nationally and internationally.
Dr. Hutter is a Past President of the American College of Cardiology, a Master of the American College of Cardiology and Fellow of the American Heart Association and a Fellow of the European Society of Cardiology. He is the Cardiologist of the Boston Bruins (NHL), the New England Patriots (NFL) and the Revolution (MLS). He is Director of the MGH Heart Center Cardiac Performance Program. A recipient of numerous awards and honors, he has been included in Who's Who in America and Guide to America's Top Physicians for many years.
Edwin Choy, MD, PhD
is the Director of Sarcoma Research at the Division of Hematology Oncology at MGH. He specialized in the medical management of patients with sarcomas, gastrointestinal stromal tumors, chordomas, and desmoid tumors. He works closely with a team of world class surgical, orthopedic, and radiation oncologists as well as connective tissue pathologists and radiologists to provide optimal care for his patients. He directs a clinical trials program at the MGH Center for Sarcoma and Connective Tissue Oncology that includes 9-12 active phase I-III clinical trials. He also maintains an active scientific research program that investigates diverse areas of sarcoma therapy ranging from the use of nanotechnology and other translational research tools aimed at developing new targeted therapies for treating cancers to preclinical studies using cell lines and animal models to better understand the molecular basis of sarcoma biology.
Dr. Andrew J. Cole is Director of the MGH Epilepsy Service, Chief of the Division of Clinical Neurophysiology and Epilepsy and Professor of Neurology at Harvard Medical School. He graduated from Dartmouth College Magna Cum Laude and Dartmouth Medical School. He trained in Neurology and Clinical Neurophysiology at the Montreal Neurological Institute, and then moved to Johns Hopkins University School of Medicine where he was Assistant Professor of Neurology. He came to Massachusetts General Hospital in 1992 where he started and developed the MGH Epilepsy Service and founded the MGH Pediatric Epilepsy Service. He has published extensively in clinical neurology, epilepsy, clinical neurophysiology and basic neuroscience. In addition to research and clinical work, Dr. Cole lectures frequently throughout the United States and internationally, and has been a visiting professor at numerous institutions in the U.S.A. and abroad.
Dr. Fifer is an expert in hypertrophic cardiomyopathy.
He graduated summa cum laude from Harvard College in 1974 and graduated from Harvard Medical School in 1978. He was an intern and resident in internal medicine at Massachusetts General Hospital and a cardiology fellow at Brigham and women's Hospital, completing his training in 1984. He is board certified in Internal Medicine and in the subspecialty of Cardiovascular Diseases.
Since 1984, he has been a staff cardiologist at Massachusetts General Hospital. He is presently director of the Hypertrophic Cardiomyopathy Program and of the cardiac catheterization laboratory.
Dr. Fifer is Associate Professor of Medicine at Harvard Medical School. He is an Associate Editor at Circulation.
Dr. Fifer's areas of expertise include hypertrophic cardiomyopathy in general and alcohol septal ablation in particular.
Rocío Hurtado, MD, is an Infectious Disease Physician and Consultant for the collaborative MDR-TB Project in Lima, Perú, with a particular emphasis on HIV/MDR-TB coinfection and treatment in resource-limited settings.
She is a graduate of the Johns Hopkins University School of Medicine, and completed her Internal Medicine Residency at the Massachusetts General Hospital. She also trained in Infectious Disease at the combined Massachusetts General/Brigham and Women's Hospital Fellowship program (including a Clinical HIV fellowship), and is board-certified in Internal Medicine and Infectious Disease. In addition, she obtained a Diploma in Tropical Medicine and Hygiene from the Liverpool School of Tropical Medicine in the United Kingdom. In 2002, she received the Edward Kass Award for Clinical Excellence in Infectious Disease from the Massachusetts Infectious Disease Society.
Dr. Hurtado has an active interest in HIV/TB coinfection in resource-limited settings, as well as the clinical interface of HIV and tropical medicine. In 2003, she was selected as an HIV trainer for the Academic Alliance for AIDS Care and Prevention in Africa, a collaborative effort between Makerere University (Kampala, Uganda) and the Infectious Disease Society of America.
She divides her time between Boston and Perú, and holds a dual appointment with the Infectious Disease Division at the Massachusetts General Hospital and the Division of Social Medicine and Health Inequalities at the Brigham and Women's Hospital. Dr. Hurtado is currently an Instructor in Medicine at Harvard Medical School.
Dr. Hayes is a staff endocrinologist in Reproductive Endocrine Associates at the Massachusetts General Hospital, an Assistant Professor of Medicine at Harvard Medical School, Clinical Director of the Reproductive Endocrine Unit Reference Laboratory, and the principal investigator on a NIH funded Patient-Oriented Career Development Award.
Dr. Hayes’ area of expertise is human reproductive physiology, a topic on which she has published widely.
Her research interests include the neuroendocrine regulation of fertility in men, specifically the interplay between gonadotropin-releasing hormone, sex steroids, and non-steroidal factors in the regulation of FSH secretion. These studies have disclosed a previously unrecognized hypothalamic site of action of estradiol in men and provide evidence that estradiol rather than testosterone is the major sex steroid regulator of FSH secretion in men. In addition, she has demonstrated that inhibin B is more important than sex steroids in the control of FSH secretion in men.
Her present research explores the relationship between testosterone and insulin resistance in men. To date, her studies have shown that insulin resistance in men is associated with a decrease in testicular Leydig cell secretion of testosterone. She is currently examining the impact of short-term medical castration on insulin sensitivity in normal healthy men as well as the impact of testosterone supplementation in men with the metabolic syndrome. Given the significant cardiovascular morbidity and mortality associated with obesity and type 2 diabetes, a clearer understanding of the interplay between testosterone and insulin resistance has important public health implications and may facilitate the development of new therapeutic strategies for these very common metabolic disorders.
Her clinical practice covers the spectrum of reproductive endocrinology including polycystic ovary syndrome, infertility, and male and female hormone replacement therapy for hypogonadism. She coordinates the NIH-sponsored program of long-term pulsatile GnRH administration for men with congenital GnRH deficiency, a therapy that is currently limited to a few academic centers in the United States. In addition, she has expertise in ovulation induction with clomiphene, gonadotropins and pulsatile GnRH for women with idiopathic or anovulatory infertility.
Dr Kuo is an Instructor of Medicine at Harvard Medical School, and an Assistant Physician and Gastroenterology Unit and Director of MGH's Gastrointestinal Motility Laboratory. He received his M.D. from Jefferson Medical School and, following residency training at the University of Texas Southwestern, he completed his fellowship at MGH. His clinical work is specialized in GI Motility and Functional GI disorders, and he has an active research lab investigating these clinical issues. His group focuses on brain gut interactions utilizing functional brain imaging, with funding from the NIH and the American Gastroenterology Association. He also conducts clinical trials in GI dysmotility and functional GI diseases such as dyspepsia, gastroparesis, gastroesophageal reflux disease, constipation, and irritable bowel syndrome.
Peter Schalock M.D. received his undergraduate degree from Linfield College, Oregon and his M.D. from Oregon Health and Science University in Portland, Oregon. After an internal medicine internship at Legacy Health System in Portland, Oregon, he completed his residency in dermatology at Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire. Dr. Schalock is a board-certified dermatologist and an Assistant Professor of Dermatology at Harvard Medical School.
He has lectured nationally and internationally on contact dermatitis (rashes caused by something contacting the skin), skin allergy testing for allergic contact dermatitis (patch testing), and rashes caused by workplace contacts (occupational skin disease). Dr. Schalock has a special interest in skin and systemic reactions caused by metal devices. He has also authored numerous scholarly articles, edited a dermatology textbook and co-authored reviews, textbook chapters, and editorials. Professionally, he is a member of the numerous societies including the American Academy of Dermatology and the American Contact Dermatitis Society, where he serves on the Society's Board of Directors and Education Committee. As well as general dermatology, his clinical and academic interests are in allergic contact dermatitis/patch testing, occupational skin diseases (work-related skin conditions, rashes), and Nevi (moles).
Brooke Swearingen is Assistant Professor of Surgery (Neurosurgery)at Harvard Medical School. He also serves as Attending Neurosurgeon at MGH. In addition, Dr. Swearingen is Co-Director of MGH's Neurological Intensive Care Unit. He has a MD from Harvard Medical School and completed his residency at MGH. Dr. Swearingen has board certification in neurosurgery. His clinical interests are pituitary tumors, cervical and lumbar disc diseases, radiosurgery (proton beam) for pituitary tumors, skull base tumors, and brain and spine tumors.
Academic Title: Instructor, Harvard Medical School
Department: Anesthesiology, Perioperative and Pain Medicine
Clinical Specialties: Anesthesia Pain Management
Medical School: Kilpauk Medical College, University of Madras (1999)
Residency: Johns Hopkins Hospital (2008) Neurology
Fellowship: Brigham and Women's Hospital (2009) Pain Management
Certification: Psychiatry and Neurology (2008)
Luke S. Oh, MD is an Attending Orthopaedic Surgeon at Massachusetts General Hospital and Associate Director of the MGH Orthopaedic Sports Medicine Fellowship Program. He is a Board Certified Orthopaedic Surgeon who holds an additional Subspecialty Certificate in Orthopaedic Sports Medicine. He is a specialist in sports medicine injuries, minimally-invasive arthroscopic surgery, and complex reconstruction of the shoulder, elbow, and knee.
Dr. Oh is an Instructor in Orthopaedics at Harvard Medical School and faculty of the Harvard/MGH Sports Medicine Fellowship, the Harvard Shoulder & Elbow Fellowship, and the Harvard Combined Orthopaedic Residency Program. He is also a member of the medical staff for several professional sports teams including the Boston Red Sox, New England Patriots, New England Revolution, Lowell Spinners. In addition, he serves as an orthopaedic surgery consultant for the Boston Bruins, Futures Collegiate Baseball League, and Harvard University.
After graduating from Cornell University, Dr. Oh attended Georgetown Medical School where he was elected to the Alpha Omega Alpha Medical Honor Society and awarded the Michael Caruso Humanitarian Award. He completed residency at the Hospital for Special Surgery and was awarded the Jean McDaniel Chief Resident Teaching and Leadership Award.
Dr. Oh completed 3 fellowships. His first was in Orthopaedic Sports Medicine at MGH where he developed proficiency in minimally-invasive shoulder and knee arthroscopy and obtained experience in the care of professional and elite athletes. The second fellowship was in Elbow and Shoulder Surgery at the Mayo Clinic where he developed expertise in cutting-edge elbow arthroscopy and complex reconstructive surgery of the shoulder and elbow. The third was an apprenticeship with Dr. James Andrews where Dr. Oh learned the Andrews technique for Tommy John ligament reconstruction for pitchers.
Dr. Oh's clinical and research interests include treatment of elbow and shoulder injuries in the throwing athlete, rotator cuff repair, complex arthroscopic and reconstructive surgery of the shoulder and elbow, complex knee ligament and meniscus surgery, and elbow and shoulder joint replacement.
His current cutting-edge research includes: 1) development of tissue engineering techniques for improvement of rotator cuff healing, 2) biomechanical investigation of dynamic shoulder joint kinematics after Latarjet coracoid transfer for shoulder instability, and 3) clinical outcomes studies of elbow function in baseball pitchers and gymnasts after arthroscopic treatment of osteochondritis dissecans (OCD) lesions.
His research initiatives have received national recognition. In 2010, Dr. Oh was the recipient of the Melvin Post Award for Excellence in Clinical Research from the American Shoulder and Elbow Surgeons for a study conducted on the outcomes and complications associated with revision total elbow replacement. In 2009, he was a member of the MGH research team that received the O'Donoghue Sports Injury Award (Best Research in Sports Medicine) from the American Orthopaedic Society for Sports Medicine for a biomechanical investigation of ligament injuries in the knee and the effect of subsequent surgical reconstruction on knee joint function.
Dr. Oh had previously been identified as an Emerging Leader by the American Orthopaedic Association and was one of 15 individuals selected nationally for participation in the Clinician-Scientist Development Program sponsored by the American Academy of Orthopaedic Surgeons, Orthopaedic Research and Education Foundation, and Orthopaedic Research Society.
Dr. Burch is a headache medicine specialist at the John R. Graham Headache Center, and is also the director of the Center's Outpatient Infusion Program. She also provides care in headache medicine at the BWH Ambulatory Center in Chestnut Hill. Dr. Burch received an MD from the University of Massachusetts Medical School and completed her Neurology residency at Boston Medical Center. She completed a fellowship in Headache Medicine at Harvard Medical School, Brigham and Women's/Faulkner Hospitals prior to joining the faculty, and is board certified in neurology and headache medicine. Her research interests include headache epidemiology and management as well as medical education. She was the recipient of a 2011 American Headache Society Fellowship Award.
Azad University School of Medicine, Medicine, 1999
Yale-New Haven Hospital, Internal Medicine, 2004
Thomas Jefferson University Hospital, Gastroenterology, 2008
Thomas Jefferson University Hospital, Transplant Hepatology, 2009
Internal Medicine, 2004
Transplant Hepatology, 2010
end-stage liver disease
I am currently a breast surgical oncologist at the Brigham and Women's Hospital and Dana Farber Cancer Institute. My primary area of interest is in neoadjuvant therapies for the treatment of breast carcinoma. I am also interested in novel imaging technology for the prediction of neoadjuvant therapy responses. We are also studying the clinical effect of Breast MRI on the ability to achieve clear margins in breast conserving therapy. Finally, we are developing minimally invasive techniques of breast surgery for both benign and malignant disease utilizing the Advanced Multimodality Image Guided Operating Suite (AMIGO).
Boston University School of Medicine
Columbia University College of Physicians & Surgeons, 2005
Brigham and Women's Hospital, General Surgery, 2006
Brigham and Women's Hospital, Neurosurgery, 2012
University of Miami Department of Neurosurgery Spine, Neurosurgery/Spine, 2013
artificial disc replacement
degenerative disc disease
minimally invasive surgery
peripheral nerve disease
spinal cord injury
spinal cord tumors
spinal fracture reconstruction
George Washington University School of Medicine, 2003
McGill University Faculty of Medicine, Orthopedic Surgery, 2008
Hospital for Special Surgery, Orthopedic Surgery, 2009
Massachusetts General Hospital, Oncology, 2010
Orthopaedic Surgery, 2013
herniated disc management
Tehran University of Medical Sciences, School of Medicine, 1995
University of Massachusetts Medical Center, Neurology, 2003
National Institutes of Health, Neuromuscular, 2005
Brigham and Women's Hospital, Neuromuscular, 2007
Neuromuscular Medicine, 2008
Dr. Jennifer Lynn Irani is an associate surgeon at Brigham and Women’s Hospital (BWH) and a surgeon for the gastrointestinal cancer treatment center at the Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC). In addition, Dr. Irani is an instructor at Harvard Medical School.
Dr. Irani received her medical degree from the University of Pennsylvania School of Medicine. She completed her general surgery residency at BWH and her colon and rectal fellowship at the University of Minnesota. Dr. Irani is board certified in surgery as well as colon and rectal surgery.
Dr. Irani has clinical interests in colon and rectal cancer, sphincter sparing surgery, Crohn’s disease and ulcerative colitis, diverticular disease, surgical management of fecal incontinence, and anorectal surgery . She performs laparoscopic surgery, robotic surgery, and traditional open surgery.
Mount Sinai School, 2000
Mt Sinai, Internal Medicine, 2003
Brigham and Women's Hospital, Gastroenterology, 2006
Brigham and Women's Hospital, Advanced Endoscopy, 2007
Internal Medicine, 2003
cancer screening and prevention
Washington University School of Medicine, 1996
Hospital of the University of Pennsylvania, Internal Medicine, 1999
Johns Hopkins Hospital, Endocrinology, 2002
Endocrinology, Diabetes and Metabolism, 2001
Internal Medicine, 1999
Dr. Jairam R. Eswara is an associate surgeon at Brigham and Women’s Hospital. Dr. Eswara received his medical degree from the Health Sciences and Technology program at Harvard Medical School in 2007. He then completed his residency in urology at Massachusetts General Hospital in 2012, and fellowship in Urologic Trauma and Reconstruction at Washington University - Barnes Jewish Hospital in 2014.
Dr. Eswara’s clinical interests include trauma and reconstruction of the genitourinary system focusing on urethral and ureteral strictures, urinary tract fistulae, continent urinary diversions, penile and urethral cancer, and urologic prosthetics. He is an active researcher whose interests include the metabolic complications of intestinal segments in the urinary tract, the utilization and outcomes of urologic trauma and reconstructive surgery, and urologic device development. He has also invented several devices for medical and surgical use.
Monica Ramirez Curtis is an Associate Physician in Rheumatology at the Brigham and Women's Hospital and an Instructor at Harvard Medical School. She graduated from Tufts University School of Medicine, and went on to complete her medical residency at Tufts Medical Center. She then completed a clinical and research fellowship in Rheumatology at the Brigham and Women's Hospital. During her fellowship, she also attended the Harvard School of Public Health and obtained an MPH. Specific areas of interest include SLE, scleroderma, rheumatoid arthritis, vasculitis, and inflammatory myopathies.
Dr. Matzkin is a former team physician for the Duke University Men’s Football team and the men’s and women’s basketball teams and currently serves as a team physician for the U.S. Women’s National Soccer Team, U.S. Paralympics Soccer Team, U.S. Women’s National Hockey Team, and she is the head team physician of Stonehill College.
Dr. Matzkin’s collaborative, multidisciplinary team represents a diverse set of specialties, including: orthopedic surgery, rheumatology, endocrinology, nutrition, physical medicine and rehabilitation, exercise physiology, and sports psychology.
Dr. Carleton Eduardo Corrales is a surgeon at Brigham and Women’s Hospital specializing in otology, neurotology and skull base surgery. He is also an instructor in otology and laryngology at Harvard Medical School.
He received his medical degree from the Autonomous University of Honduras. Dr. Corrales completed an otolaryngology residency and a neurotology and skull base surgery fellowship at Stanford University Medical Center. His interests include diseases of the ear, otosclerosis and stapes surgery, superior canal dehiscense, hearing loss and acoustic neuroma (vestibular schwannoma).
Assistant Professor of Orthopedic Surgery
Brigham and Women's Hospital
Brigham and Womens Hospital Orthopaedic Surgery
75 Francis St
Boston MA 02115
07/2013 - current: Brigham and Women’s Hospital Department of Neurology
Director, Division of Neurological Infections and Associate Neurologist, Division of Hospital Neurology
07/2013 - current: Johns Hopkins University School of Medicine, Adjunct Assistant Professor, Department of Neurology
07/2013- current: Harvard Medical School, Instructor of Neurology
07/2012 – 06/2013 Johns Hopkins University, Department of Neurology, Clinical Fellow in Neuroimmunology and Neurological Infections
07/2009 – 06/2012 Harvard Neurology Residency Program, Neurology Resident
06/2008 – 06/2009 Massachusetts General Hospital, Internal Medicine Intern
08/2005 – 05/2008 Georgetown University School of Medicine, Doctor of Medicine
AREAS OF EXPERTISE
- Neurological infections
- Inflammatory conditions of the nervous system
Dr. Akshay Suvas Desai is a cardiovascular medicine specialist and the director of the Heart Failure Disease Management Program at Brigham and Women’s Hospital (BWH). In addition, he is an assistant professor of medicine at Harvard Medical School (HMS).
Dr. Desai received his medical degree from HMS. He completed an internal medicine residency, as well as fellowships in cardiovascular medicine, vascular medicine and advanced heart disease at BWH. He is board certified in internal medicine and cardiovascular disease.
His clinical interests include advanced heart failure, congenital heart disease and cardiac transplantation. The author of over 40 peer-reviewed publications, Dr. Desai’s research focuses on improving care and outcomes for heart failure patients, as well as strategies to reduce heart failure readmissions. His research has received support from the American College of Cardiology and the National Heart, Lung and Blood Institute.
Dr. Bertram Zarins received his MD degree with honors from SUNY Upstate Medical University in Syracuse in l967. He did an internship and assistant residency in general surgery at the Johns Hopkins Hospital in Baltimore. Dr. Zarins completed the Harvard Combined Orthopaedic Residency Program in l973 and a fellowship in Sports Medicine at the Massachusetts General Hospital.
Dr. Zarins is the Augustus Thorndike MD Clinical Professor of Orthopaedic Surgery at the Harvard Medical School. He started the Sports Medicine Service at the Massachusetts General Hospital and was its Chief until 2007. He was a pioneer in the development of arthroscopic surgery and in anterior cruciate ligament (ACL) surgery. Dr. Zarins was the head team physician for the Boston Bruins (NHL) for 32 years, the New England Patriots (NFL) for 24 years, and the New England Revolution (MLS) for 14 years. Dr. Zarins served on the US Olympic Committee Sports Medicine Council for 12 years and was head physician for the XIV Winter Olympics in Sarajevo in l984. Dr. Zarins has been Chairman of the American Academy of Orthopaedic Surgeons Committee on Sports Medicine and was the Consulting Editor for Sports Medicine for the Journal of Bone and Joint Surgery.
Dr. Zarins is a specialist in the treatment of injuries to the knee and shoulder and in arthroscopic surgery. He specializes in anterior cruciate ligament (ACL) reconstruction and other knee ligament and cartilage injuries. He also is an expert in the treatment of shoulder rotator cuff injuries and shoulder instability (dislocations and subluxations).
Clnical Director, Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute in Boston.
Assistant Professor of Medicine, Harvard Medical School
I am a graduate of Cornell University Medical College, did medical residency at NYU-Bellevue, and a Hematology-Oncology fellowship at Beth Israel Hospital in Boston.
Dr. Parisa Lotfi is a women's and oncology imaging radiologist at the Brigham and Women's Hospital, Faulkner Hospital and Dana Farber Cancer Institute in Boston. Dr. Lotfi has expertise in the interpretation of mammography, ultrasonograhpy, computed tomography, magnetic resonance imaging, PET imaging of malignant and benign conditions. With nearly a decade of experience at Harvard Medical School affiliated Hospitals, Dr. Lotfi provides outstanding patient centered experience for both local, national and international clientele.
Diler Acar, MD, is an assistant professor in the Department of Neurology at Harvard Medical School. She is a board certified neurologist and behavioral neurologist and neuropsychiatrist and director of Brigham and Women's Faulkner Hospital Behavioral Neurology Service. Dr. Acar received her medical degree from Istanbul University Medical School. She completed her residency in Neurology at Tufts University and finished two year fellowship in Behavioral neurology and neuropsychiatry at Brigham and Women's Hospital. Her expertise is in neurodegenerative diseases, learning disorders and neuropsychiatric manifestation of variety of neurological conditions.
Dr. Brian Nahed specializes in Brain tumors (Glioblastoma, Gliomas, Metastatic Brain Tumors and Meningiomas) and Spinal Disorders. He has clinical appointments in the Brain Tumor and Cancer Center, Stephen E. and Catherine Pappas Center for Neurooncology. He is an Assistant Professor and teaching faculty member of Harvard Medical School and Massachusetts General Hospital.
Dr. Brian Nahed's research focuses on circulating brain tumor cells and metastatic disease. In collaboration with Drs. Daniel Haber and Shyamala Maheswaran, Dr. Nahed's research has received several grants and awards and has been presented at national conferences. Dr. Nahed is actively enrolling patients with brain tumors into his research study. Dr. Brian Nahed is an active member of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, and serves on national committees for the Tumor Section and Council of State Neurological Surgeons.
Jay S. Loeffler, M.D., completed his medical degree at Brown University School of Medicine in Providence, Rhode Island. Since 1986 he has served on the staff at Harvard Medical School where he completed his residency and chief residency in radiation oncology. He is currently the Herman & Joan Suit Professor of Radiation Oncology, Harvard Medical School, Massachusetts General Hospital where he serves as Chairman of the Department of Radiation Oncology. Dr. Loeffler is an authority on the treatment of primary and malignant brain tumors. He is an author of 150 peer reviewed publications and editor of 6 textbooks. He is the principal investigator on a large program project grant concerning proton therapy. He serves on the Editorial Boards of International Journal of Radiation Oncology Biology and Physics, Neurosurgery, Nature Oncology, The Oncologist, Technology in Cancer Research and Treatment, and Journal of Neuro-Oncology.
Joseph C. Kvedar, MD, a board-certified dermatologist, is the Founder and Director of the Center for Connected Health and Vice-Chair of Dermatology, Harvard Medical School. Dr. Kvedar’s primary responsibilities involve direction and management of the Center for Connected Health, a service of Harvard-affiliated teaching hospitals. Dr. Kvedar is immediate Past Chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine. He co-authored the initial set of AAD telemedicine guidelines and participated in their subsequent revisions. He also serves as Chair of the Association of Professors of Dermatology Curriculum Committee with a focus on the ACGME competencies. Dr. Kvedar is recognized internationally for his forward thinking in creating the next generation of communication technologies in health care. The Center for Connected Health’s programmatic platform includes digital home health, online second opinion consultations, interactive consultations and underserved population health care initiatives. It has an extensive service in clinical and educational videoconferencing and multimedia productions that link and provide information to health care providers world-wide. Dr. Kvedar’s academic interest focuses on the systematic study of how the clinical care process can be performed in a time and place independent of a specialist while preserving quality of care. He has been a senior author or major contributor in several major publications addressing aspects of this theme. For example, Kvedar was among the first to show that a series of still digital images can substitute for the dermatologic physical exam as published in Arch Dermatol. 1997;133:161-167. Dr. Kvedar is Past President of the American Telemedicine Association (ATA).
Leroy Parker serves as Associate Clinical Professor of Medicine at Harvard Medical School. Dr. Parker earned his MD from Johns Hopkins University in 1969, and received postdoctoral training at Johns Hopkins Hospital and the National Institutes of Health. He trained in medical oncology at DFCI, joining the staff in 1973. His clinical focus is breast cancer, and he also conducts patient-related clinical research. He has board certification in Internal Medicine and Medical Oncology.
George Demetri is an Associate Professor of Medicine at Harvard Medical School. Dr. Demetri received his MD from Stanford University in 1983, followed by an internal medicine residency and chief residency at the University of Washington Hospital, Seattle, and a fellowship in medical oncology at DFCI in 1989. He is director of the Center for Sarcoma and Bone Oncology at DFCI, director of the Ludwig Center at Dana-Farber/Harvard Cancer Center, and executive director for Clinical and Translational Research at the Ludwig Institute for Cancer Research.
Kenneth Anderson is the Kraft Family Professor of Medicine at Harvard Medical School. Dr. Anderson graduated from Johns Hopkins Medical School, trained in internal medicine at Johns Hopkins Hospital, and completed hematology, medical oncology, and tumor immunology training at DFCI. He serves as chief of the Division of Hematologic Neoplasia, director of the Jerome Lipper Multiple Myeloma Center, and vice chair of the Joint Program in Transfusion Medicine at DFCI.
Dr. Freedman is an Associate Professor of Medicine at Harvard Medical School, and at Dana-Farber Cancer Institute in the Department of Medical Oncology and Attending Physician at Brigham and Womens Hospital. He is the Clinical Director of the Lymphoma Program at DFCI. Dr. Freedman has focused on clinical and laboratory research in non-Hodgkin's lymphomas. A graduate of Brandeis University, Dr. Freedman received his M.D. from University of Massachusetts Medical School, and came to Dana-Farber as a fellow in medical oncology in 1982.
Dr. Freedman's research interests have focused on the development of new therapies for non-Hodgkin's lymphoma. This includes efforts are toward enhancing the effects of antibody based therapies and understanding how the tumor microenvironment can be manipulated in the treatment of lymphomas.
Daniel DeAngelo is an Assistant Professor of Medicine at Harvard Medical School. He practices oncology at DFCI, focusing on treating Leukemias, Myelodysplasia, and Myeloproliferative Disorders. Dr. De Angelo received his MD and PhD from Albert Einstein College of Medicine in 1993, followed by residency in internal medicine at Massachusetts General Hospital. He served a clinical fellowship in hematology and oncology at the Brigham and Women's Hospital and DFCI, where he joined the staff in 1999.
Dr. Lori J. Wirth is an Instructor of Medicine with the Head and Neck Oncology Program at the Dana-Farber Cancer Institute, one of the first multi-disciplinary head and neck cancer programs established in this country.
Dr. Wirth graduated in 1987 from Brown University and received her MD from Columbia University College of Physicians and Surgeons in New York in 1997. She completed a residency in Internal Medicine at at New York Presbyterian Hospital in 2000 and became a fellow in Medical Oncology at the Dana-Farber Cancer Institute. She completed her fellowship in 2003 and became an Instructor.
Michael O'Leary is a urologist at BWH. He recieved his medical education from Harvard Medical School and George Washington University, and completed an internship at Tufts Medical School. O'Leary's residencies, both in urology, were completed at Tufts Medical School and MGH. His fellowship was at University of California at San Francisco School of Medicine. O'Leary's clinical interests are benign prostatic hypertrophy, male infertility, male sexual dysfunction, prostate cancer, and stone disease.
Jeffrey Morgan is an oncologist at DFCI and an Instructor in the Department of Medicine at Harvard Medical School. He has a MD from Harvard Medical School and completed both his residency and his fellowship at Brigham and Women's Hospital. Dr. Morgan is board certified in Hematology and Internal Medicine.
Chandrajit Raut is an associate surgeon of oncology at Brigham and Women's Hospital and an instructor in surgery at Harvard Medical School. He recieved his MD from Harvard and completed his residency at MGH. His fellowship is from M.D. Anderson Cancer Center, and he is board certified in surgery. Raut's clinical interests are sarcoma and gastrointestinal oncology. Dr. Raut's research focus is in the multidisciplinary management of sarcomas.
Patrick Wen is an Associate Professor of Neurology at Harvard Medical School. Dr. Wen graduated from the Medical College of St. Bartholomew’s Hospital, University of London, in 1981. He completed his internal medicine training at the University of London postgraduate hospitals and his neurology residency in the Harvard-Longwood Neurology Training Program. His research is focused on novel treatments of brain tumors, especially targeted molecular agents. His other clinical interests include neurologic complications of cancer.
Paul Marcoux is an Instructor in Medicine at Harvard Medical School and a member of its Thoracic Oncology Group. He has board certification in Internal Medicine, Hematology, and Oncology. Dr. Marcoux has a MD from University of Minnesota School of Medicine, completed his residency at University of Massachusetts Memorial Medical Center in Internal Medicine, and completed his fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center.
Robert I. Haddad, MD, is Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts. He is Clinical Director/Head and Neck Oncology Program, and a member of the Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Dr. Haddad received his medical degree from Saint Joseph University, French Faculty of Medicine, Beirut, Lebanon, and served as intern and resident at St. Luke’s Roosevelt Hospital Center, New York, New York. He served a fellowship in hematology/oncology at Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland. Dr. Haddad’s current research activity involves the use of intensive chemoradiotherapy regimens for patients with locally advanced head and neck cancer with particular attention to radioprotection. He is also involved in a large phase III study comparing sequential chemoradiotherapy to concomitant chemoradiotherapy: The Paradigm Trial. Dr. Haddad lectures extensively on head and neck cancer, both on the regional and the national level.
Akila Viswanathan, MD MPH: Physician, Radiation Oncology, Dana Farber Cancer Institute and Brigham & Women’s Hospital. After attending Harvard University for her undergraduate studies, and the University of Pittsburgh School of Medicine, Dr. Viswanathan completed her Internal Medicine Internship at Beth Israel Deaconess Medical Center. Dr. Viswanathan then completed a Radiation Oncology Residency and served as Chief Resident at the Joint Center for Radiation Therapy, Harvard Medical School. Board Certified in Radiation Oncology, Dr. Viswanathan maintains clinical interests in Gynecologic Radiation Oncology.
Matthew Kulke, MD joined the DFCI staff in 1997 and is currently an Assistant Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute. He completed his undergraduate education at Princeton University, and received an M.D. from the University of California, San Francisco School of Medicine in 1992. He subsequently completed an internship and residency in internal medicine at Brigham and Women's Hospital, and a fellowship in medical oncology at Dana-Farber Cancer Institute. Dr. Kulke has led a multi-institutional trial of the novel angiogenesis inhibitor SU11248 in patients with neuroendocrine tumors, and has also served as study chair for a large, randomized trial of pancreatic cancer therapies performed by the Cancer and Leukemia group B. His recent efforts have focused on the evaluation of novel treatment agents and the identification novel treatment targets in neuroendocrine tumors.
Dr. Nghiem is a dermatologist at the Dana-Farber Cancer Institute who specializes in skin cancers and is a recognized specialist in Merkel cell carcinoma in the Harvard medical system. He has cared for over one hundred patients with MCC and has read, lectured and written about this rare and challenging disease. Dr. Nghiem conducts basic science research on cancer biology at the Cutaneous Biology Research Center at Massachusetts General Hospital. His contributions to the MCC literature can be viewed at his laboratory website at http://www.pnlab.org. Dr. Nghiem is interested in defining the optimal treatment for MCC. Towards that end, he is maintaining a clinical database and tumor bank to better analyze this rare disease. In addition, he will be leading genetic studies to further understand the biology of MCC.
Dr. Abrams received his medical degree from Jefferson Medical College in 2000. He subsequently completed his residency in internal medicine and his fellowship in medical oncology at University of Michigan Hospital.
George Velmahos, MD, PhD, MSEd is the Chief of Trauma, Emergency Surgery, and Surgical Critical Care at the Massachusetts General Hospital. He is also the John F. Burke Professor of Surgery at Harvard Medical School. He specializes in the treatment of severe injuries (abdominal, thoracic, etc) as well as major surgical emergencies (for example, perforations, obstructions, bleedings, or acute inflammations of the gastrointestinal tract). He also has a strong interest in hernia repairs with a emphasis on massive hernias, requiring abdominal wall reconstruction. He is a Fellow of the American College of Surgeons, the Royal College of Surgeons of Edinburgh, the Royal College of Physicians and Surgeons of Glasgow, and the American College of Critical Care Medicine. He has authored over 300 peer-review publications and more than 40 books and book chapters. He is actively involved in international medical programs of the Massachusetts General Hospital and the American College of Surgeons.
Raymond Chung is an assistant professor in the Department of Medicine at Harvard Medical School, as well as Director of Hepatology at Massachusetts General Hospital. He is the medical director of MGH's Liver Transplant Program. He graduated Yale University School of Medicine with a MD, and completed his residency at Johns Hopkins Hospital. Chung's fellowship was completed at MGH. His clinical interests are Hepatitis C virus, viral Hepatitis, liver transplantation, hepatology, and HIV.
Lee M. Kaplan, MD, PhD, is Director of the MGH Weight Center and the Obesity Research Center, Associate Chief for Research of the MGH Gastroenterology Unit and an Associate Professor of Medicine at Harvard Medical School. Dr. Kaplan graduated from Harvard University and the Albert Einstein College of Medicine. He completed his Internship and Residency in Internal Medicine and his Fellowship in Gastroenterology at the Massachusetts General Hospital and Harvard Medical School. Dr. Kaplan’s clinical expertise is in the areas of gastrointestinal and liver diseases, with a particular focus on viral hepatitis, metabolic and fatty liver disease, gastrointestinal endocrine tumors, and obesity. The author of more than 100 published papers, he has a special interest in the causes and complications of obesity and the development of new and more effective preventive strategies and therapies for this problem. His current research is focused on the regulation of body weight, the mechanisms of weight loss and improvement in insulin sensitivity after gastric surgery, and the causes and treatment of fatty liver disease.
Bruce H. Price, MD: Chief, Department of Neurology, McLean Hospital. After graduating in 1975 from the University of Cincinnati College of Medicine, Dr. Price would complete a Behavioral Neurology Fellowship at Beth Israel Deaconess Hospital and Harvard Medical School. Board Certified in Psychiatry and Neurology, Dr. Price maintains clinical interests in Cognitive and emotional consequences of brain disease, Dementia, and Traumatic Brain Injuries. Dr. Price has authored numerous papers for medical journals and has been recognized for his contributions to the field of neurology.
Michael Schwarzschild, MD: Associate Professor of Neurology, Harvard Medical School, Neurology Service, Massachusetts General Hospital. With a medical degree from Harvard Medical School and a PhD from Harvard University, Dr. Schwarzschild completed his residency in Neurology and a fellowship in Movement Disorders at Massachusetts General Hospital. Board Certified in Neurology, Dr. Schwarzschild maintains clinical interests in Parkinson’s Disease, Movement Disorders in Women, and Neuroprotective Strategies. Dr. Schwarzschild has been published in many leading medical journals as well as recognized for his work in combating Parkinson’s Disease.
Michael Bierer, MD, MPH: Medicine Service, Massachusetts General Hospital. Educated at Albert Einstein College of Medicine, Yeshiva University, Dr. Bierer completed his post-graduate education at Massachusetts General Hospital. Board Certified in Internal Medicine, Dr. Bierer’s clinical interest is in Addiction Medicine. Awarded for outstanding service to Homeless Mental Health consumers in greater Boston, Dr. Bierer is certified by the American Society of Addiction Medicine. Published in leading academic journals on substance abuse issues, Dr. Bierer speaks Spanish and French.
Sang-Gil Lee, MD: Clinical Research Associate, Orthopaedic Surgery, Massachusetts General Hospital. Dr. Lee specializes in microvascular surgery, peripheral nerve surgery, and congenital deformities. His medical education began at the University of Oklahoma College of Medicine. He then completed Surgery Internship and an Orthopedic Surgery Residency at the University of Chicago Hospital before finishing a Fellowship in Hand Surgery at the Raymond Curtis Hand Center. Dr. Lee is Board Certified in Orthopaedic Surgery and Hand Surgery. Dr. Lee also speaks Korean.
Christopher Kwolek, M.D.: Surgery Service, Massachusetts General Hospital. Dr. Kwolek attended the University of California, San Francisco, before completing his residency at New England Deaconess Hospital in General Surgery. He followed that with a Vascular Surgery Fellowship at Massachusetts General Hospital and an Endovascular Surgery Fellowship at the Arizona Heart Institute. The author many articles and publications, Dr. Kwolek maintains clinical interests in Endovascular Surgery, Thoracic and Abdominal Aortic Stent Grafts, Carotid Angioplasty and Stenting, Peripheral Thrombolysis and Angioplasty, Renal and Visceral Artery Angioplasty and Stenting. Dr. Kwolek directs the endovascular training program at the Massachusetts General hospital.
David Ring, MD: Director of Research, Hand and Upper Extremity Service, Department of Orthopaedic Surgery, Massachusetts General Hospital. Assistant Professor of Orthopaedic Surgery, Harvard Medical School. Dr. Ring is was educated at the University of California at San Diego, both undergraduate and medical school, and trained in orthopaedic surgery and hand and microvascular surgery at the Harvard Combined Orthopaedic Residency and Massachusetts General Hospital. Dr. Ring has published over 150 scientific articles and a commonly used textbook on hand and wrist surgery. He is an internationally renowned educator, participating in dozens of national and international conferences each year. He has received numerous awards and honors, most recently being elected to the prestigious American, British, and Canadian Exchange Fellowship (2005), the oldest and most prestigious traveling fellowship in the world. Dr. Ring’s treats the full spectrum of arm problems with a special clinical, teaching, and research interest in fractures and post-traumatic reconstruction (stiff elbows, nonunion, and heterotopic bone for example) and a research interest in the psychosocial influences on arm illness.
Nicolas Y. Bu-Saba, MD, FACS is Assistant Professor of Otology and Laryngology at Harvard Medical School. Dr. Bu-Saba received his medical degree from American University of Beirut in Lebanon in 1985. He completed several residencies and internships in Surgery and Otolaryngology at the American University of Beirut Medical Center, Beth Israel Deaconess Medical Center and Massachusetts Eye and Ear Infirmary. With Board Certification in Otolaryngology and Head and Neck Surgery, Dr. Bu-Saba currently practices at the Massachusetts Eye and Ear Infirmary as well as the VA Medical Center. His specialties include Rhinology-Sinus disease, snoring and sleep apnea, general otolaryngology with research interests in Gene mutations and sinusitis, clinical research in the field of sinus disorders and sleep apnea.
James Cusack, M.D.: Assistant Professor of Surgery, Harvard Medical School; Division of Surgical Oncology, Massachusetts General Hospital. Dr. Cusack’s clinical interests include Gastrointestinal Cancer, Liver Metastases, Colon Cancer, Experimental Therapeutics, and Gene Therapy. Dr. Cusack completed a residency in surgery at the Tufts, New England Medical Center, Boston, MA; a research Fellowship in surgery at Brigham and Women’s Hospital, and a Fellowship in Surgical Oncology at U.T.M.D., Anderson Cancer Center in Houston, TX.
Dr. Campos received her MD from Georgetown University in 1992, and then completed residency training at Georgetown Medical Center. Between 1995 and 1998, she completed a fellowship in hematology-oncology at Brigham and Women's Hospital, in Boston, and in 2000 received her MPH from Harvard Medical School. She serves on committees for the American Society of Clinical Oncology, the Gynecological Oncology Group, and the National Comprehensive Cancer Network. She is board-certified in internal medicine, oncology, and hematology.
Jean-Valery Coumans, M.D.: Neurosurgery Service, Massachusetts General Hospital. Dr. Coumans graduated from the University of Rochester School of Medicine before completing his internship and residency at Georgetown University Medical Center, and a fellowship in spinal surgery at the Cleveland Clinic. His area of interest includes spinal tumors, degenerative spine disease of the cervical and lumbar spines and complex spinal disorders. The recipient of many awards and honors, Dr. Coumans maintains a busy clinical practice and continues to author influential articles.
Annekathryn Goodman, MD: Director, Gynecology-Oncology Fellowship Program, Massachusetts General Hospital; Associate Professor, Obstetrics and Gynecology and Reproductive Biology, Harvard Medical School. Recognized as one of Boston’s Best Doctors in 2001, Dr. Goodman has been in practice for over fourteen years. After graduating from Tufts University School of Medicine, Dr. Goodman completed an Obstetrics and Gynecology Internship and Residency at Tufts affiliated hospitals before finishing a Gynecologic Oncology Fellowship at Massachusetts General Hospital. Dr Goodman maintains clinical interests in Gynecologic Malignancies, Complex Pelvic Surgery, Palliative Care, and Acupuncture.
Mark Pasternack, M.D.: Medicine Service, Pediatric Service, Infectious Disease Unit, and Chief, Pediatric Infectious Disease Unit, Massachusetts General Hospital. Educated at Harvard Medical School, Dr. Pasternack completed his residency and clinical infectious disease fellowship at Massachusetts General Hospital and a research fellowship at the Center for Cancer Research, Massachusetts Institute of Technology. Author of numerous papers and articles for prestigious medical journals, Dr. Pasternack is an officer of the Massachusetts Infectious Diseases Society and a member of the Pediatric Infectious Disease Society as well as the Infectious Diseases Society of America. His broad clinical interests include Infectious Disease and Pediatric Infectious Disease.
Kevin Raskin, MD: Dr. Raskin specializes in Musculoskeletal Tumor Surgery (orthopaedic oncology): Adult and Pediatric Bone and Soft Tissue Tumors. His clinical interests are in Limb-Salvage surgery, massive bone loss surgery, and skeletal deformity. He is currently an Instructor of Orthopaedic Surgery at Harvard Medical School and Associate Surgeon, Orthopaedic Surgery, at Massachusetts General Hospital. Dr. Raskin attended the University of Tel Aviv Sackler School of Medicine. He completed his residency in Orthopaedic surgery in New York City and Fellowship training at Massachusets General Hospital.
Jon J.P. Warner, M.D. joined the Harvard Combined Orthopaedic Surgery Dept. on April 1, 1998 as Associate Professor of Orthopaedic Surgery, Partner’s Health Care System and Chief of the Harvard Shoulder Service at Partners. He has since been promoted to Full Professor in June 2004. He has offices at Massachusetts General Hospital and Brigham and Women’s Hospital. He comes to Boston from the University of Pittsburgh where he was Associate Professor of Orthopaedic Surgery, Director of the Shoulder Service, Assistant Director of the Center for Sports Medicine, and Co-Director of the Shoulder Research Laboratory at the Musculoskeletal Research Center. Under his direction over the eight years when he worked there Pittsburgh became known as one of the preeminent centers for management of problems of the shoulder, and also as the premier research center for study of biomechanics of the shoulder. He has authored over 80 peer review publications, more than 200 book chapters, and 4 books. His clinical and basic research has been recognized by more than 30 regional, national and international awards. These have included the Kappa Delta Award of the American Academy of Orthopaedic Sureons (Best Research in Orthopaedics), The O’Donoghue Award of the American Orthopaedic Society for Sports Medicine (Best Research in Sports Medicine), The Neer Award of the American Shoulder and Elbow Surgeons (Best Research in Shoulder Problems), The John Joyce Award of the International Arthroscopy Association, The O’Connor Award of the Arthroscopy Association of North America (Best Research in Arthroscopy), and the Award for Best Paper of the Orthopaedic Trauma Society. In 1994 he was selected as one of the two traveling fellows in the inaugural year of the American Shoulder and Elbow Surgeons Exchange Fellowship representing this society to The European Society of Shoulder and Elbow Surgeons. He has been a Visiting Professor and Lecturer on 300 occasions at meetings and Universities throughout Europe, Asia, and the United States.
He is Board Certified in Orthopaedic Surgery and is a member of numerous specialty societies including the Orthopaedic Research Society, the American Shoulder and Elbow Surgeons, the American Orthopaedic Society for Sports Medicine, and the Arthroscopy Association of North America. His practice is principally devoted to the treatment of problems of the shoulder and elbow.
Li-Li Hsiao, M.D., Ph.D. FACP
Language: English, Mandarin, Taiwanese
Dr. Hsiao, a member of the WIN (Women in Nephrology), ASN (American Society of Nephrology) and ISN (International Society of Nephrology), joined the faculty of the Renal Division at the Brigham and Women Hospital, Harvard Medical School in 2004. She received her Ph.D. degree from Department of Pathology and Cell Biology at Thomas Jefferson University in 1988 and M.D. degree from Jefferson Medical College in 1995. Dr. Hsiao completed her medical residency and chief residency at Medical College of Pennsylvania in Philadelphia, PA and a fellowship in Nephrology at Massachusetts General Hospital-Brigham and Women’s Hospital, Harvard Medical School in Boston, MA. Dr. Hsiao has received many honors and awards throughout her career thus far including an Alpha-Omega-Alpha membership for Medical Honor society. She is currently a faculty member, an Associate Physician at Brigham and Women’s Hospital and an Instructor at Harvard Medical School.
Dr. Hsiao participates in the clinical work of the Division by attending on the Dialysis Ward and Consult services. She also has a regular out patient clinic focusing on chronic kidney diseases. Currently, Dr. Hsiao is the Program Director of “Asian Renal Clinic/International IgA Nephropathy Referral Center” at Brigham and Women’s Hospital, This program is designed to be a renal referral center serving large Asian population in Greater Boston area and around the world. Dr. Hsiao has been identified as a Nephrology specialist by International office; patients from around the world such as Turkey, Kuwait, and Saudi Arabia have been consulting Dr. Hsiao for managing various renal diseases. Her area of expertise covers all aspects of chronic kidney disease (CKD). She is particular interested in (1) preventing progression of CKD (2) CKD- related bone disease (3) CKD- related anemia (4) Hypertension management in CKD patients (5) proteinuria management in CKD patients (6) Nutrition in CKD patients (7) dialysis access creation. As the Program Director of Asian Renal Clinic/International IgA Nephropathy Referral Center, one of Dr. Hsiao’s main focus of research is to study the effects of Herbal medicine on renal toxicity and cytoprotection.
Dr. Hsiao shares her experiences in renal physiology and pathophysiology by giving lectures to medical students at Harvard Medical School, by teaching the mechanism-based approach informally when she attends on the ward and consult services. She was given a teaching award by Harvard Medical School, class 2003. She is also a member of admission committee at Harvard Medical School. She is very passionate about humanity. She is helping to develop programs where experiences in medical knowledge, techniques and quality patient care can be exchanged between two Institutions.
James Lehrich is the Assistant Professor of Neurology at MGH. He graduated from Harvard Medical School in 1962, and went on to complete residencies in medicine and neurology at MGH and Columbia-Presbyterian Hospital, respectively. Lehrich specializes in neurology and is particulary interested in multiple sclerosis and diseases of the spine.
John M. Siliski, M.D. is an orthopaedic practice specializing in adult knee and hip surgery. Conditions treated include ligament and cartilage injuries, fractures, osteoarthritis, rheumatoid, inflammatory, and post-traumatic arthritis. Surgical procedures include arthroscopy, ligament reconstruction, fracture fixation, and total knee and minimally invasive total hip replacements. Siliski is the editor of the book Traumatic Disorders of the Knee. He graduated from the Harvard Medical School with a MD and has been in the profession for 30 years.
David Forcione practices Gastroenterology and Internal Medicine in Boston, Massachusetts. He graduated from Boston University of Medicine with a MD and has been in the profession for 9 years. Both his residency and one of his fellowships were completed at MGH; his other fellowship was completed at Brigham and Women's Hospital. Along with Field Willingham, Forcione has contributed information about Cowden's Syndrome to the DAVE Project, a colletion of teaching tools.
John Levinson is an active clinical cardiologist who joined MGH in 1989. He is interested in the application of computer technology to clinical practice. Levinson is also a professor at Harvard Medical School. He graduated from Stanford University School of Medicine with an MD. His clinical interests include general clinical cardiology, arrhythmia, valvular heat disease, and coronary artery disease.
Thomas MacGillivry is a cardiac surgeon at MGH. He has an MD from Tufts University School of Medicine and his clinical interests include acquired heart disease, heart transplantation, congenital heart disease, mechanical support, and disease of the thoracic aorta. His residencies were completed at MGH and Boston Children's Hospital,and his fellowship was at University of California San Francisco. MacGillivry has been researching clinical device trials for mechanical circulatory support.
Patrick Ellinor practices cardiology, clinical cardiac electrophysiology, and internal medicine in Boston, Massachusetts. Dr. Ellinor graduated from Stanford University School Of Medicine with a MD and has been in the profession for 11 years. As a graduate student he worked in the laboratory of Dr. Richard Tsien performing structure and function studies on voltage dependent calcium channels. He then went to Brigham and Women's Hospital for his medical residency followed by training in cardiology and cardiac electrophysiology at Massachusetts General Hospital. Dr. Ellinor has appointments in the Cardiac Arrhythmia Service and in the Cardiovascular Research Center. Since 2003, Dr. Ellinor has been the Director of the Cardiac Step-Down Unit and the Co-Director of the Fellowship Program in Cardiac Electrophysiology at MGH.
Timothy Guiney graduated from Harvard Medical School with a MD. He has lifetime board certifications in cardiovascular disease and internal medicine. Dr. Guiney's clinical interests are clinical cardiology, preoperative evaluation, and exercise testing. He is on the medical advisory board of the Atrial Fibrillation Foundation, and is medical director of the International Patient Center at MGH.
Steven M. Zeitels, MD, FACS, is the Eugene B. Casey Chair of Laryngeal Surgery at Harvard Medical School (HMS) and the Director of the Center for Laryngeal Surgery and Voice Rehabilitation at the Massachusetts General Hospital (MGH). In addition, Dr. Zeitels serves as Laryngologist to the voice departments and theatres throughout Boston.
Dr. Zeitels has been a productive surgical innovator designing more than 15 new laryngeal and pharyngeal procedures as well as two patented laryngoscopes. His major research interests include laryngeal microsurgery, especially as it relates to minimally-invasive surgical oncology; phonosurgery and voice disorders; medical and surgical management of performing artists; design and development of endoscopic instruments; and the history of laryngology and head and neck surgery. Dr. Zeitels has contributed more than 140 scientific articles, book chapters, exhibits, and videotapes in these areas as well as presenting over 300 papers and lectures. He serves or has served on the editorial board of 5 national and international journals. He has been the visiting professor at 20 departments, universities, and hospitals including, Memorial Sloan Kettering, University of Cincinnati, University of Utah, Vanderbilt University, University of Navarra - Pamplona / Spain, Tel Aviv University / Israel, and Aukland University / New Zealand.
Dr. Zeitels has received ~50 awards and honored lectureships for his achievements including the Casselberry Award from the American Laryngological Association. Among his many national and international lectureships, he has served as the Lewis H. Wright Memorial Distinguished Lecturer for the American Society of Anesthesiology, Sylvan Stool History of Medicine Lecturer - University of Pittsburgh School of Medicine, and the Arnold Grossman Lecturer in Laryngology - McGill University, as well as honored guest of the British Voice Association, the Spanish Head and Neck Society, the 1st annual meeting of the Brazilian Society of Laryngology and Voice, the New Zealand Society of Otolaryngology, and the Chilean Head & Neck Society.
Dr. Zeitels is a committed academic surgeon working locally, nationally and internationally to advance laryngology and head and neck surgery. His work has been featured in the Harvard Medical Alumni Journal, the Harvard Magazine and the BU Alumni Journal and discussed extensively in print media, radio, and television both nationally and internationally [i.e. Good Morning America, Boston Globe, NPR, BBC, Nightline, Boston – New York – LA television news] He conceived and directs the Voice Restoration Research Program, which is a collaborative effort of investigators at HMS, MGH, MIT. He is currently the President of the American Broncho-Esophagological Association. Dr. Zeitels recently re-established a Harvard Laryngeal Surgery service at the MGH, which had not been present since the 1920s. Dr. Zeitels was a member of the 1st class of Boston University (BU) Trustee Scholars, attended the BU 6-year medical program, and graduated from the BU School of Medicine in 1982. He completed the Boston University - Tufts University combined Otolaryngology – Head and Neck Surgery Program in 1987 as well as a Head & Neck Surgical Oncology Fellowship at Boston University and the Boston Veterans Affairs Medical Center in 1988.
Marcela del Carmen is an assistant professor in the Department of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. She is also an assistant in the Gynecologic Oncology Service at Massachusetts General Hospital. In addition, del Carmen serves as the clinical director at the Gillette Center for Gynecologic Oncology. Her MD comes from Johns Hopkins University School of Medicine, and she also has a Masters in Public Health from Harvard University. Del Carmen is certified by American Board of Obstetrics and Gynecology and
Gynecologic Oncology. Her residency was at Johns Hopkins Hospital School of Medicine, and her fellowship and research fellow were both completed at Massachusetts General Hospital. Dr. del Carmen's clinical interests are health disparities among minority women and surgical treatment of ovarian cancer.
Dr. Bleday practices Colon & Rectal Surgery and General Surgery in Boston, Massachusetts. He graduated from McGill University School of Medicine with a MD. He has board certification in Colon & Rectal Surgery and Surgery. Dr. Bleday's clinical interests are sphincter sparing surgery in rectal cancer, surgery for crohn's and colitis, and laparoscopic assisted colectomy. He is affiliated with surgery, general and gastrointestinal surgery, surgery, and cancer.
Dr. Greenberger, who joined the Division of Gastroenterology in March 2002, is a Senior Attending Physician and Clinical Professor of Medicine at Harvard Medical School. He received his A.B. from Yale University and, following receipt of his M.D. from Western Reserve University School of Medicine, he completed medical residency training at the University Hospital of Cleveland in Cleveland, OH, and Gastroenterology fellowship training at the Massachusetts General Hospital. Following appointments at the Ohio State University College of Medicine, in 1972, Dr. Greenberger joined the faculty of the University of Kansas School of Medicine, where he has served as Chief of the Division of Gastroenterology, Chairman of the Department of Medicine and, recently, Senior Associate Dean for Medical Education and Senior Associate Dean for Academic Affairs. Dr. Greenberger is a past President of the American Gastroenterological Association, the American College of Physicians, the Central Society for Clinical Research and the Association of Professors of Medicine. He is the author or co-author of more than 230 publications including chapters in major medical texts. His clinical research interests focus on gastroesophageal reflux disease, inflammatory bowel disease, alcoholic liver disease, hepatitis C and acute and chronic pancreatic disease.
Jonathan Coblyn is the Director of the Center for Arthritis and Joint Diseases at Brigham and Women's Hospital. He graduated from Johns Hopkins University School of Medicine. His residencies were at Peter Bent Brigham Hospital/Harvard Medical School and Stanford University Hospital, and his fellowship was at Robert Breck Brigham Hospital. Coblyn has board certification in Internal Medicine and Rheumatology. His clinical interests are rheumatoid arthritis, osteoarthritis, pmr/vasculitis, regional musculoskeletal disorders, systemic lupus, and systemic rheumatic diseases.
Wendy Chen is an Instructor in Medicine at Harvard Medical School. Dr. Chen received her MD from the University of Pennsylvania in 1993. She completed her internal medicine residency at the Brigham and Women's Hospital and her fellowship in hematology-oncology at the Dana-Farber Partners Cancer Program. She received her MPH from the Harvard School of Public Health in 1999. She has been on staff at the Dana-Farber Cancer Institute and a research associate at the Channing Laboratory since 1999.
Vicki Heller practices Obstetrics & Gynecology at BWH. She graduated Harvard Medical School and completed her internship and residency at Brigham and Women's Hospital. Heller's clinical interests include fibroids, infertility, menopause, menstrual abnormalities, and ovarian cysts. She belongs to The American College of Obstetricians and Gynecologists.
Dr. Fanta serves as Director of the Partners Asthma Center and as Medical Director of the Pulmonary Unit at Youville Hospital. His interests span the gamut of pulmonary diseases, including asthma, COPD, bronchiectasis, sarcoidosis, and pulmonary fibrosis. He has been selected as one of the Top Doctors in Pulmonary Medicine by Boston Magazine (March, 2003) and was cited in Castle Connolly's America's Top Doctors, 2002. He is the recipient of a number of awards at Brigham and Women’s Hospital for his teaching and patient care, including the Dennis Thompson Compassionate Care Scholar Award.
David Lhowe is an orthopaedic surgeon at MGH. He has a MD from Case Western Reserve University School of Medicine and is board certified in orthopaedic surgery. Lhowe's clinical interests are fracture care, nonunions and malunions, and hip and knee problems. Dr. Lhowe is an accomplished orthopaedist who specializes in hip and knee replacement surgery and trauma surgery. He is a well-respected clinician and educator, and he has special interest and experience in disaster and mass casualty medicine
David Kanarek practices Internal Medicine and Pulmonology at MGH. He has a MD from University of Witwatersrand in Johannesburg, South Africa. Dr. Kanarek's residency was completed at Johannesburg Hospital, and his fellowship was in pulmonology at MGH. He is board certified in Internal Medicine and Pulmonary Disease. Kanarek's clinical interests are Pulmonary Disease, COPD, and Interstitial Lung Disease.
Thomas DeLaney is the Medical Director at Francis H. Burr Proton Therapy Center. He has a MD from Harvard Medical School and completed his residency in Radiation Oncology at MGH. Dr. DeLaney is board certified in Radiation Oncology. He is Co-Director at MGH's Center for Sarcoma and Connective Tissue Oncology, as well as Associate Professor of Radiation Oncology at Harvard Medical School. His clinical interests are Sarcomas and other Connective Tissue Tumors, and Proton Radiotherapy & Brachytherapy.
William Curry is an Instructor in Surgery (Neurosurgery)at Harvard Medical School and an Attending Neurosurgeon at MGH. He has a MD from Cornell University Medical College, and completed his residency at MGH in neurosurgery. He is board certified in neurosurgery. Dr. Curry's clinical interests are Benign and Malignant Brain Tumors; Spine and Spinal Cord Tumors; Metastatic Tumors to the Spine; Neurofibromatosis; and Immunotherapy for Brain Tumors.
Giuseppe Barbesino is a thyroid specialist at MGH. He has a MD from Universita Cattolica del Sacro in Rome, Italy. His residency was completed at University of Massachusetts in Worcester, and his fellowship was at Mt. Sinai Hospital. He has board certification in Internal Medicine and Endocrinology & Metabolism. Dr. Barbesino's clinical interests are Thyroid Nodules, Thyroid Cancer, and General Endocrinology.
Igor Palacios is the Director of Knight Catheterization Laboratory at MGH. He graduated the University of Venezuela with a MD, and has board certification in Internal Medicine (Lifetime), Cardiovascular Disease (Lifetime), and Interventional Cardiology. Dr. Palacios' clinical interests are Interventional Cardiology, Coronary Artery Disease, Valvular Heart Disease.
Dror Michaelson is an oncologist at MGH. He has both a MD and a PhD from Albert Einstein College of Medicine. Dr. Michaelson completed his residency in Internal Medicine at Brigham & Women's Hospital. His fellowship was in Adult Oncology at Dana-Farber/Partners CancerCare. Michaelson is board certified in Internal Medicine and Medical Oncology. He is an instructor at Harvard Medical School and an assistant in medicine at MGH. His clinical interests are Prostate Cancer; Renal Cancer; Bladder Cancer; Testicular Cancer; and Phase I Clinical Trials.
W. Scott McDougal is the Chief of Urology Service at MGH and the director of MGH's Urology Residency. He has a MD from Cornell University Medical College, and has lifetime board certification in Urology and Surgery. Dr. McDougal's clinical interests are Urologic Oncology and Reconstructive Urology.
Assistant in Neurology, Movement Disorders Unit and General Neurology Unit
Dr. Mejia's clinical practice centers on caring for patients with Parkinson disease and other movement disorders. Her research aims to help all patients receive the best possible neurologic care and clinical outcomes.
Roy Perlis, MD studied neuroscience at Brown University and earned his medical degree at Harvard Medical School. He completed an internship in internal medicine at Massachusetts General Hospital serving as Chief Resident in Psychopharmacology. He is currently a staff psychiatrist at the Bipolar Program and an Assistant Professor at Harvard Medical School. His interests include psychiatric genetics and treatment-refractory mood disorders.
Alphonse Taghian is an Associate Professor in the Departments of Radiation Therapy and Radiation Oncology at HMS, and an Associate in Radiation Oncology at MGH. He is the Chief of MGH's Radiation Oncology Breast Services. Dr. Taghian has a MD from Alexandria Medical School in Egypt, and a PhD from Paris XI University in Paris, France. He completed two residencies in radiation oncology in Paris, France: at the Alexis Vautrin Cancer Center and the Gustave Roussy Institute. He also completed a fellowship in radiation oncology at MGH. He has board certification in radiation oncology in both France and the USA. Dr. Taghian's clinical interest is Partial Breast Irradiation.
Nagagopal Venna is a neurologist at MGH. He has a MD from Guntur Medical College in India and has lifetime board certification in neurology. His clinical interests are General Neurology, Peripheral Neuropathies, Dementia, Giat Disorders, Neurology of HIV, Neurology of Infectious Diseases, and Neurology of Systemic Disease.
Elizabeth Thiele is the Director of the Pediatric Epilepsy Program at MGH and an Associate Professor of Neurology at HMS. She graduated Johns Hopkins University School of Medicine with a MD and a PhD. She had residencies in pediatrics at The John's Hopkins Hospital and the Children's Hospital in Boston. Her fellowship was also at the Children's Hospital, in neurology. Dr. Thiele has board certification in Neurology with Special Qualification in Child Neurology and Clinical Neurophysiology. Her clinical interests are Tuberous Sclerosis Complex, Ketogenic Diet, and Neurocognitive Aspects of Epilepsy.
Joseph Bonventre is a Professor of Medicine and Health Sciences and Technology at Harvard Medical School and Director of the Harvard-MIT Division of Health Sciences at Brigham & Women’s Hospital. He is Chief of the Renal Division in the Department of Medicine at BWH and the Director of the Division of Health Sciences and Technology at MGH. Dr. Bonventre has a Ph.D. in Biophsyics from Harvard University; a M.D. from Harvard Medical School; and a B.S. in Engineering Physics from Cornell University.
Ferdinando Buonanno is the Co-Director of Pediatric Stroke Service and an Assistant Neurologist at MGH. He is also an Assistant Professor Of Neurology at HMS. He recieved his MD from University of Padova in Italy. Dr. Buonanno completed his residencies at Bowman Gray School of Medicine, and University of Padova; his fellowships were in Stroke and Cerebrovascular at MGH, and in Stroke at Bowman Gray School of Medicine. He has board certification in neurology and his clinical interests are Stroke and Cerebrovascular Disease.
John Petrozza is the Chief of the Massachusetts General Hospital Fertility Center and the Chief of the Vincent Reproductive Medicine and IVF Division. Petrozza graduated University of Texas Medical Branch with his MD. He completed his residency in Obstetrics and Gynecology at the University of Texas Health Center. Dr. Petrozza's fellowship was in Reproductive Endocrinology and Infertility, at Tufts University School of Medicine. He has board certification in Obstetrics/Gynecology, and Reproductive Endocrinology and Infertility. Petrozza is a member of the American Society of Reproductive Medicine, the Boston Fertility Society, the Association of Professors of Gynecology and Obstetrics, and the American Association of Gynecologic Laparoscopists.
John Growdon is a Neurologist at MGH and a Professor of Neurology at HMS. He recieved his MD from University of Pennsylvania and completed his residency at University of Chicago. Dr. Growdon's fellowships were in neurology at MGH and in neurochemistry at MIT. He is board certified in Neurology and Psychiatry. Growdon specializes in Alzheimer's disease, related memory disorders, and Parkinson's disease. His clinical interests are neurotransmitter function in neurodegenerative disease and pharmacology of neurodegenerative disease.
Jeremy D. Schmahmann received his medical degree in 1980 at the University of Cape Town, winning the Nestle Prize for pediatrics and the Wilfrid Exner Bauman Prize for best student in the final year. After completing residency in the Neurological Unit of the Boston City Hospital, he trained as a postdoctoral fellow in the Department of Anatomy and Neurobiology at Boston University School of Medicine. He joined the faculty of Massachusetts General Hospital in 1989, where he is Director of the Ataxia Unit, a member of the Cognitive/Behavioral Neurology Unit and the Geriatric Neurobehavior Clinic, and Neurology Clerkship Director. Dr. Schmahmann is Professor of Neurology at Harvard Medical School,and a Scholar in the Academy at Harvard. He won the Norman Geschwind Prize in2000 for research in behavioral neurology from the American Academy of Neurology and the Behavioral Neurology Society, recognizing his contribution to the field of the cerebellum and cognition. Dr. Schmahmann has received numerous teaching awards and honors, including the Distinguished Neurology Teacher Award from the American Neurological Association in 2008. He is a Fellow of the American Academy of Neurology, Fellow of the American Neuropsychiatric Association, member of the medical research advisory board of the National Ataxia Foundation, and he has been cited in The Best Doctors in America since 1998.His neurological and neuroanatomical research is funded by the NationalInstitutes of Health, and by private foundations. Dr. Schmahmann has more than 110 publications in peer-reviewed journals and academic texts, and his published books include The Cerebellum and Cognition (Academic Press), MRI Atlas of the Human Cerebellum (Academic Press), and Fiber Pathways of the Brain (Oxford University Press) that was awarded the 2006 Medical Science Award for best book in the category of medical publications by the American Association of Publishers.
James Greenberg is Chief of Gynecology at Faulkner Hospital and Vice Chairman of OB/Gyn at Brigham & Women's Hospital
Assistant Professor: Harvard Medical School.
New York University
Brigham & Women's and Massachusetts General Hospitals
Minimally invasive surgeries; fibroids; general obstetrics
Andrew Freiberg is an Assistant Professor of Orthopaedics and the Chief of Arthroplasty Service at MGH. He recieved his MD from University of Cincinnati and is board certified in Orthopaedic Surgery. Dr. Freiberg's clinical interests are Total Hip and Knee Replacement.
Victor Neel is the Director of MGH Dermatologic Surgery. He graduated Princeton University and later recieved his MD from Cornell University Medical College and his PhD from Rockefeller University. Neel completed his dermatology residency at Brown University School of Medicine. He became a fellow at Mohs Micrographic Surgery and Cosmetic Dermatology, UCLA School of Medicine. Dr. Neel is board certified in dermatology. His clinical interests are Mohs Surgery, Skin Cancer Surgery, Minimally-invasive aesthetic surgery, and Liposuction.
Arthur Sober is the Associate Chief of MGH's Department of Dermatology, the Director of the MGH Melanoma Center/Pigmented Lesion Clinic, and the Medical Director of the Dermatology Associates and Dermatology Outpatient Unit. He is also a Professor in the Department of Dermatology at Harvard Medical School. Dr. Sober recieved his MD from George Washington University School of Medicine and has lifetime board certifications in Dermatology and Internal Medicine. Dr. Sober's clinical interests are Cutaneous Melanoma, Skin Cancer, and General Dermatology.
Amita Sharma practices thoracic radiology at MGH. She was a Consultant Radiologist a Barts & The London NHS Trust and an Instructor in Radiology at HMS. Sharma's MD and internship were both at King’s College School of Medicine & Dentistry, UK. Her residencies were at King’s College Hospital & Barts & The London NHS Trust, and in Thoracic Radiology at MGH. Dr. Sharma has board certification in radiology. Her clinical interests are Lung Cancer, Lung Transplantation, and Lung Biopsy and Radiofrequency Ablation.
David S. Walton, MD is boarded in both Pediatrics and Ophthalmology. He completed his ophthalmic training at the Massachusetts Eye and Ear Infirmary. Currently he is Clinical Professor of Ophthalmology at Harvard Medical School. He has a unique practice that contains a high percentage of childhood glaucoma cases. His research interest is on the mechanisms of childhood glaucomas.
John Loewenstein is an Associate Professor at Harvard Medical School, and is also the MEEI Associate Chief of Ophthalmology. He specializes in Retina/Vitreous disorders, and he recieved his MD from State University of New York. His residency was in ophthalmology and his fellowship was in retina; both were at Boston University Affiliated Hospitals. Dr. Loewenstein is board certified in ophthalmology. He is a member of the American Academy of Ophthalmology, Retina Society, Association for Research in Vision and Ophthalmology, Inc. (ARVO), The New England Ophthalmological Society (NEOS), and Massachusetts Society of Eye Physicians and Surgeons.
Dr. Fay completed his medical studies at Columbia University's College of Physicians and Surgeons and an ophthalmology residency at the Edward S. Harkness Eye Institute. He went on to a fellowship in oculoplastics and orbital surgery at the Massachusetts Eye and Ear Infirmary, where he is also an assistant surgeon. He currently serves as an assistant professor at Harvard Medical School and is a founding member of the Hemangioma and Vascular Malformations Clinic at Massachusetts General Hospital. Dr. Fay is also a fellow of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) and of the American Academy of Ophthalmology (AAO).
Aaron Waxman is an Assistant Professor at Harvard Medical School's Pulmonary and Critical Care Unit. He got his PhD from Albany Medical College and recieved his MD from Yale School of Medicine. His residency was completed at Yale-New Haven Hospital in Internal Medicine, and he became a fellow at
Yale School of Medicine in Pulmonary and Critical Care Medicine. Dr. Waxman has board certification in Critical Care Medicine, Internal Medicine, and Pulmonary Disease. His clinical interests are Asthma, Critical Care, Acute Lung Injury, Sepsis, Pulmonary Embolism, and Pulmonary Vascular Disease including Pulmonary Arterial Hypertension.
Ali Tavakkolizadeh is an Associate Surgeon at BWH who specializes in Gastroenterology. He recieved his MD from The London Hospital Medical College and interned at Royal London Hospital. His residencies were completed at Royal College of Surgeons of England (FRCS) and BWH, and his fellowship was at Harvard Advanced Minimally Invasive Surgery Fellowship. Dr. Tavakkolizadeh has board certification in surgery and his clinical interests are gallstones, hernias, GERD and reflux disease, laparoscopic gastrointestinal surgery, laparoscoic splenectomy and other solid organs, and laparoscopic gastric bypass surgery and lap band.
Alice Flaherty is the Director of the Movement Disorders Fellowship Program at MGH and an instructor in neurology at HMS. She recieved her MD from Harvard Medical School, and her PhD from Massachusetts Institute of Technology. Her residency and fellowship were at Massachusetts General Hospital in Internal Medicine,
Neurology, and Movement Disorders. She is board certified in neurology. Dr. Flaherty's clinical interests are Parkinson's disease, tremor, intersection of psychiatry and neurology, deep brain stimulation, movement and mood disorders, and writer's block.
Alireza Atri is a neurologist at Massachusetts General Hospital and Harvard Medical School. He recieved his MD from University of California, San Francisco, and completed his residency at BWH in internal medicine. Dr. Atri has board certification in neurology and his clinical interests include Memory Disorders, Dementias, Alzheimers Disease, MCI, CJD, and Parkinson's Plus Syndromes.
Andrew Warshaw is a W. Gerald Austen Professor in HMS' Department of Surgery, and Surgeon-in-Chief and Chairman of the Department of Surgery at MGH. He graduated Harvard Medical School with his MD and completed his residency in surgery at MGH. Dr. Warshaw is a Clinical Associate in the Section on Gastroenterology at the National Institute of Arthritis and Metabolic Diseases, Bethesda. He is also a Research Fellow in Medicine at HMS, a Clinical and Research Fellow in Medicine at MGH, and a Clinical Fellow in Surgery at HMS. Dr. Warshaw is board certified in surgery and surgical critical care. His clinical interests are Pancreatic and Hepatobiliary Surgery, Gastrointestinal Surgery, Oncological Surgery.
Anne Louise Oaklander MD, PhD, is an Assistant Professor of Anesthesiology and Neurology at Harvard Medical School, and an Assistant Neurologist and Neuropathologist at the Massachusetts General Hospital. After an undergraduate degree in Neuroscience from Cornell University, she received her MD and PhD from the Albert Einstein College of Medicine where she studied the cell biology of peripheral nerve degeneration. She was selected as Chief Resident during her neurology residency at the University of Medicine and Dentistry of New Jersey, and is Board Certified in Neurology. She moved to the Johns Hopkins School of Medicine where she was awarded an NIH fellowship to study Peripheral Nerve Disease with Dr. Jack Griffin in the Department of Neurology. She then completed a fellowship in Neurosurgical Management of Pain at Hopkins. She joined the Neurosurgery faculty at Hopkins and, in 1998, moved to Mass General where she is an attending physician in the MGH Pain Center. She is nationally recognized for her clinical expertise in diagnosis and management of chronic neuropathic pain, and for her research studies that usually use actual human pain patients.
Antonia Stephen is an Assistant in Surgery in MGH's Division of Surgical Oncology, as well as an Instructor in Surgery at Harvard Medical School. She recieved her MD from HMS and was a resident in general surgery at MGH. Dr. Stephen completed a fellowship in Endocrine Surgery at Cleveland Clinic Foundation, and her research fellowship was at the Pediatric Surgical Research Laboratory at Massachusetts General Hospital. She is board certified in surgery, and her clinical interests are Thyroid and Parathyroid Surgery; Adrenal Surgery; Head and Neck Surgery; Endocrine Surgery, Melanoma; Hyperparathyroidism; and Thyroid Cancer.
April Eichler is an Instructor at HMS' Department of Neurology and an Assistant in Neurology in MGH's Neuro-Oncology department. Her MD is from University of Pittsburgh School of Medicine and she was a neurology resident at MGH and BWH. Dr. Eichler's fellowships were in Neuro-Oncology at MGH and DFCI. She has board certification from the American Academy of Psychiatry and Neurology. Her clinical interest is Metatastic and Primary Brain Tumors.
Benedict Cosimi is the Surgical Director of the Pancreas, Islet and Small Bowel Transplantation Program at MGH. He is chief of the transplantation unit at MGH and professor of surgery at Harvard Medical School. Dr. Cosimi served on the OPTN/UNOS organ procurement and distribution intestinal allocation subcommittee and the OPTN/UNOS xenotransplantation study group. He also has served on his region's liver review board. He currently is president of the American Society of Transplant Surgeons (ASTS) and president of the organizing committee of the 2006 World Transplant Congress, a joint meeting of the ASTS, American Society of Transplantation (AST) and The Transplantation Society (TTS). He has served as vice president of TTS and as chair of its ethics committee. Dr. Cosimi is immediate past president of the New England Surgical Society and also has served as chair of the board of trustees of the New England Organ Bank in Newton, Mass. He earned a medical degree at the University of Colorado School of Medicine in Denver.
In 1990 Dr. Medoff received his BS with honors in Molecular Biophysics and Biochemistry from Yale University. He received his MD in 1994 from Harvard Medical School. Dr. Medoff completed his residency at Massachusetts General Hospital in 1997 and served as chief resident from 1999-2000. He completed his fellowship training in pulmonary and critical care in 2001 from the Harvard Combined Fellowship. Dr. Medoff currently attends in the Medical Intensive Care Unit where he serves as the Associate Director. He also conducts research into the basic mechanisms of lung disease. He is board certified in Internal Medicine, Pulmonary Disease, and Critical Care Medicine. Dr. Medoff's clinical interests are Acute Respiratory Distress Syndrome, Asthma, and Mechanical Ventilation.
Dr. Grottkau is chief of pediatric orthopedics at Massachusetts General Hospital. He is a graduate of Harvard College, Harvard Medical School, and the Harvard Combined Orthopaedic Residency Training Program, having served his Chief residency at the MGH on the East Orthopaedic Service. He completed a fellowship in Adult Spinal Surgery at the New England Baptist Hospital followed by a combined Pediatric Orthopaedic Fellowship at Children’s Hospital in Boston and the University of California.
Carolyn Krasner is a gynecologic oncologist at MGH. She recieved her MD from University of Vermont College of Medicine, and both her residency and fellowship were at Beth Israel Deaconess Medical Center. Dr. Krasner has board certification in Internal Medicine, Medical Oncology, and Hematology. Her clinical interests are Gynecologic Malignancies; Intraperitoneal Chemotherapy; and
Joseph C. Kvedar, MD, a board-certified dermatologist, is the Founder and Director of the Center for Connected Health and Vice-Chair of Dermatology, Harvard Medical School. Dr. Kvedar’s primary responsibilities involve direction and management of the Center for Connected Health, a service of Harvard-affiliated teaching hospitals.
Dr. Kvedar is immediate Past Chair of the American Academy of Dermatology (AAD) Task Force on Telemedicine. He co-authored the initial set of AAD telemedicine guidelines and participated in their subsequent revisions. He also serves as Chair of the Association of Professors of Dermatology Curriculum Committee with a focus on the ACGME competencies.
Dr. Kvedar is recognized internationally for his forward thinking in creating the next generation of communication technologies in health care. The Center for Connected Health’s programmatic platform includes digital home health, online second opinion consultations, interactive consultations and underserved population health care initiatives. It has an extensive service in clinical and educational videoconferencing and multimedia productions that link and provide information to health care providers world-wide.
Dr. Kvedar’s academic interest focuses on the systematic study of how the clinical care process can be performed in a time and place independent of a specialist while preserving quality of care. He has been a senior author or major contributor in several major publications addressing aspects of this theme. For example, Kvedar was among the first to show that a series of still digital images can substitute for the dermatologic physical exam as published in Arch Dermatol. 1997;133:161-167.
Dr. Kvedar is Past President of the American Telemedicine Association (ATA).
I am an Instructor of Radiation Oncology at Harvard Medical School and the Massachusetts General Hospital. My clinical practice focuses on the treatment of men with prostate cancer and other urologic malignancies. My clinical research focuses on adverse effects of hormonal therapy for prostate cancer, long-term outcomes and late toxicities with bladder-sparing chemoradiation, the effects of obesity and lifestyle modification on cancer control, as well as investigations into the comparative effectiveness of proton beam therapy for prostate cancer of which the current proposal is a main priority. I hold a doctorate degree in cancer genetics and remain active in translational science. I am actively involved in clinical trial design and with the Radiation Therapy Oncology Group (RTOG), where I am the Principal Investigator of a Phase II study using proton beam radiation therapy with androgen deprivation for locally advanced prostate cancer and serve as the lead for proton evaluation in RTOG's translational research program.